Treating irAEs without compromising cancer treatment response One important challenge with treating irAEs is ensuring that the approaches do not interfere with antitumor responses
If the FDA ends the shortage and you cannot afford branded tirzepatide, work with your prescriber to transition to a lower-cost GLP-1 alternative like semaglutide (if covered) or to develop a maintenance plan that includes dietary structure and possible lower-dose continuation if financially feasible
This is a real-world, non-randomized study: inevitably subject to selection bias, adherence differences, unbalanced comorbidities, and socioeconomic or prescribing factors that may explain some of the observed differences
The psychogenic and addictive properties of cocaine are mediated, at least in part, through the blockade of DAT-mediated DA reuptake and an increase in extracellular DA
For Novo, the next drug on the horizon is called CagriSema